Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|64|3|191-206

ISSN： 0030-2414

Source： Oncology, Vol.64, Iss.3, 2003-04, pp. : 191-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

Role of gemcitabine in the treatment of ovarian cancer

By AbuShahin Fadi   Rose Peter G  

Women's Health, Vol. 3, Iss. 3, 2007-05 ,pp. : 279-290

Future Medicine

Access to resources Recommend Favorite

Xeloda® in the Treatment of Metastatic Breast Cancer

By  

Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. : 16-20

Karger

Access to resources Recommend Favorite

The Evolving Role of Gemcitabine in the Management of Breast Cancer

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

By  

Oncology, Vol. 60, Iss. 4, 2001-06 ,pp. : 303-307

Karger

Access to resources Recommend Favorite